Scalper1 News
Biotech Relypsa (RLYP) soared in afternoon trading Friday as reports spread that it was nearing a sale. Shortly before noon, Street Insider quoted an anonymous source saying that Merck (MRK) was about to make an offer for Relypsa for an unknown price. About an hour and a half later, the Financial Times reported that its own anonymous source said that Relypsa was merely starting the process without a particular buyer, though GlaxoSmithKline (GSK) Scalper1 News
Scalper1 News